Emerging technologies have the potential to transform healthcare, but are in the midst of a complex transition from a physician preference and fee driven environment to a more complex, value-based care system. For medical technologies, this has created unique challenges in ensuring that product value is clearly articulated and fully realized across a range of stakeholders, from regulators, physicians, hospitals, and payers. Identifying and clearly articulating the value of innovation is important not only for early stage companies but also the large multinational players that are seeking to grow market share and their offerings.
We have extensive experience working across different medical technologies and unique situations, conducting opportunity assessments and diligences, informing commercialization and reimbursement strategies, or developing the strategic direction for a technology or business unit. Our clients span all company sizes, from small startups to large pharma, and we can tailor our expertise to best meet individual needs.
We are deeply familiar with navigating the medical technology landscape across all major developed and emerging markets, and are well-positioned to help develop global strategies to maximize product and company value.
Opportunity Prioritization
Optimal Technology Application Identification
Indication Prioritization
Competitive Landscape Analysis
Customer Profiling & Segmentation
Reimbursement Strategy
Payer Value Proposition Assessment
Clinical Utility and Evidence Generation Strategy
Global P&MA Landscape Assessment
Market Entry and/or Development Strategy
Corporate Growth Strategy
Business Unit Strategy
Adjacency Assessment
Buy- and Sell-side Diligence
Licensing and Acquisition Support
